Feb 6, 2016 12:36
8 yrs ago
1 viewer *
English term
SECURE study
English to Spanish
Medical
Medical (general)
protocol
Outcomes for the SECURE Study will be compared to data collected from the U.S. Healthcare Cost and Utilization Project family of databases and/or contemporary literature.
Proposed translations
(Spanish)
4 +2 | estudio SECURE | Rodrigo Castillo H. |
Change log
Feb 6, 2016 12:36: changed "Kudoz queue" from "In queue" to "Public"
Feb 8, 2016 06:53: Karen Zaragoza changed "Vetting" from "Needs Vetting" to "Vet OK"
Proposed translations
+2
2 days 4 hrs
Selected
estudio SECURE
«SECURE» es la sigla de «Study to Evaluate Contraceptive Use, Reliability and Effectiveness». Lo recomendable sería expandir la sigla la primera vez que aparece y agregar la traducción al español entre paréntesis. Aquí te dejo una referencia donde aparece el término expandido:
«PRINCETON, N.J., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the initiation of its Phase 3 study called SECURE (Study to Evaluate Contraceptive Use, Reliability and Effectiveness). The SECURE study is designed to assess the efficacy, safety and tolerability of Agile's investigational once-weekly transdermal contraceptive patch, Twirla™ (AG200-15). Twirla will be the only low-dose combined hormonal contraceptive patch and delivers the active ingredients ethinyl estradiol and levonorgestrel, both of which have an established history of efficacy and safety in currently marketed combination low-dose oral contraceptives.» (http://bit.ly/20RiUrg)
Suerte
--------------------------------------------------
Note added at 2 días4 horas (2016-02-08 16:49:46 GMT)
--------------------------------------------------
O «ensayo SECURE».
«PRINCETON, N.J., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the initiation of its Phase 3 study called SECURE (Study to Evaluate Contraceptive Use, Reliability and Effectiveness). The SECURE study is designed to assess the efficacy, safety and tolerability of Agile's investigational once-weekly transdermal contraceptive patch, Twirla™ (AG200-15). Twirla will be the only low-dose combined hormonal contraceptive patch and delivers the active ingredients ethinyl estradiol and levonorgestrel, both of which have an established history of efficacy and safety in currently marketed combination low-dose oral contraceptives.» (http://bit.ly/20RiUrg)
Suerte
--------------------------------------------------
Note added at 2 días4 horas (2016-02-08 16:49:46 GMT)
--------------------------------------------------
O «ensayo SECURE».
4 KudoZ points awarded for this answer.
Comment: "Selected automatically based on peer agreement."
Something went wrong...